Jennifer Baldock Sells 5,798 Shares of Surgery Partners (NASDAQ:SGRY) Stock

Surgery Partners, Inc. (NASDAQ:SGRY) insider Jennifer Baldock sold 5,798 shares of Surgery Partners stock in a transaction that occurred on Thursday, March 12th. The shares were sold at an average price of $13.17, for a total transaction of $76,359.66. Following the transaction, the insider directly owned 326,474 shares of the company’s stock, valued at approximately $4,299,662.58. This trade represents a 1.74% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link.

Jennifer Baldock also recently made the following trade(s):

• On Friday, March 6th, Jennifer Baldock sold 10,082 shares of Surgery Partners stock. The stock was sold at an average price of $13.70, for a total transaction of $138,123.40.

Surgery Partners Stock Performance

SGRY stock traded up $0.01 during midday trading on Monday, hitting $12.39. 1,509,638 shares of the stock traded hands, compared to its average volume of 1,747,282. Surgery Partners, Inc. has a 1-year low of $12.25 and a 1-year high of $24.60. The company has a debt-to-equity ratio of 1.15, a current ratio of 1.87 and a quick ratio of 1.71. The stock’s fifty day simple moving average is $14.95 and its 200-day simple moving average is $17.72. The firm has a market cap of $1.60 billion, a P/E ratio of -19.98 and a beta of 1.95.

Surgery Partners (NASDAQ:SGRY) last issued its quarterly earnings data on Monday, March 2nd. The company reported $0.12 earnings per share for the quarter, missing analysts’ consensus estimates of $0.31 by ($0.19). Surgery Partners had a positive return on equity of 1.28% and a negative net margin of 2.35%.The firm had revenue of $885.00 million during the quarter, compared to analyst estimates of $866.54 million. During the same quarter last year, the company posted $0.44 EPS. The company’s revenue was up 2.4% on a year-over-year basis. On average, analysts expect that Surgery Partners, Inc. will post 0.67 earnings per share for the current year.

Surgery Partners declared that its Board of Directors has authorized a stock buyback plan on Thursday, February 26th that allows the company to repurchase $200.00 million in shares. This repurchase authorization allows the company to reacquire up to 9.7% of its stock through open market purchases. Stock repurchase plans are generally an indication that the company’s leadership believes its shares are undervalued.

Analysts Set New Price Targets

A number of equities analysts have issued reports on SGRY shares. UBS Group reiterated a “buy” rating on shares of Surgery Partners in a research report on Wednesday, March 11th. JPMorgan Chase & Co. reduced their target price on Surgery Partners from $27.00 to $20.00 and set a “neutral” rating for the company in a research note on Monday, November 24th. Benchmark reiterated a “buy” rating on shares of Surgery Partners in a research report on Tuesday, March 3rd. Cantor Fitzgerald reissued an “overweight” rating on shares of Surgery Partners in a research note on Wednesday, March 4th. Finally, US Capital Advisors set a $21.00 price target on shares of Surgery Partners in a report on Wednesday, March 11th. Eight analysts have rated the stock with a Buy rating, two have assigned a Hold rating and one has given a Sell rating to the stock. According to MarketBeat, Surgery Partners presently has an average rating of “Moderate Buy” and a consensus price target of $23.36.

Institutional Investors Weigh In On Surgery Partners

Several institutional investors have recently bought and sold shares of the company. State of Wisconsin Investment Board boosted its holdings in Surgery Partners by 0.4% in the 4th quarter. State of Wisconsin Investment Board now owns 151,504 shares of the company’s stock worth $2,341,000 after buying an additional 668 shares during the last quarter. ProShare Advisors LLC raised its holdings in shares of Surgery Partners by 6.9% during the fourth quarter. ProShare Advisors LLC now owns 14,135 shares of the company’s stock valued at $218,000 after acquiring an additional 909 shares during the last quarter. Jones Financial Companies Lllp lifted its position in shares of Surgery Partners by 313.1% in the third quarter. Jones Financial Companies Lllp now owns 1,227 shares of the company’s stock valued at $27,000 after acquiring an additional 930 shares in the last quarter. California State Teachers Retirement System lifted its position in shares of Surgery Partners by 1.6% in the second quarter. California State Teachers Retirement System now owns 65,091 shares of the company’s stock valued at $1,447,000 after acquiring an additional 1,021 shares in the last quarter. Finally, Police & Firemen s Retirement System of New Jersey boosted its stake in shares of Surgery Partners by 7.2% in the second quarter. Police & Firemen s Retirement System of New Jersey now owns 17,582 shares of the company’s stock worth $391,000 after acquiring an additional 1,176 shares during the last quarter.

Surgery Partners Company Profile

Surgery Partners, Inc operates as a healthcare services provider specializing in the management and ownership of ambulatory surgery centers, surgical hospitals and multispecialty rehabilitation hospitals across the United States. Through its network of facilities, the company coordinates and delivers a broad range of outpatient surgical procedures in specialties such as orthopedics, ophthalmology, otolaryngology, gastroenterology, pain management and general surgery. Its integrated platform offers ancillary services including on-site imaging, laboratory testing, infusion therapy and physical, occupational and speech rehabilitation.

Since its establishment in 2010 and subsequent public listing in 2015, Surgery Partners has focused on strategic partnerships with physicians and health systems to expand access to cost-effective outpatient care.